Conor Quinn

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Escherichia Coli

Pluripotent Stem Cells

Capillary Electrophoresis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Conor Quinn, Julen Tomás-Cortázar, Oritsejolomi Ofioritse, Joanne Cosgrave, Claire Purcell, Catherine McAloon, Susanna Frost, Siobhán McClean
GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection. Vaccines 11 (1) (2023)
Conor Quinn, Julen Tomás-Cortázar, Oritsejolomi Ofioritse, Joanne Cosgrave, Claire Purcell, Catherine McAloon, Susanna Frost, Siobhán McClean
GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection. Vaccines 11 (1) (2023)
Conor Quinn, Julen Tomás-Cortázar, Oritsejolomi Ofioritse, Joanne Cosgrave, Claire Purcell, Catherine McAloon, Susanna Frost, Siobhán McClean
GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection. Vaccines 11 (1) (2023)
Conor Quinn, Julen Tomás-Cortázar, Oritsejolomi Ofioritse, Joanne Cosgrave, Claire Purcell, Catherine McAloon, Susanna Frost, Siobhán McClean
Correction: Quinn et al. GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection. Vaccines 2023, 11 , 175. Vaccines 11 (9) (2023)
Conor Quinn, Julen Tomás-Cortázar, Oritsejolomi Ofioritse, Joanne Cosgrave, Claire Purcell, Catherine McAloon, Susanna Frost, Siobhán McClean
GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection. Vaccines 11 (1) (2023)